RZRazeena Zahid

Razeena Zahid

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Razeena Zahid has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Two decades of pulmonary vascular disease and ischemic heart disease mortality in the united states: A longitudinal analysis using CDC WONDER (1999–2020)

    by Areesha Nawaz, Fnu Hafeezullah, Zainab Ali Siddiqui, Muhammad Shaheer Bin Faheem, Nazeer Ahmed, Razeena Zahid, Ali Zubair, Bushra Ghullam Muhammad, Jawad Ibrahim, Muhammad Raafay Jamil, et al.

    Pulmonary vascular disease (PVD) and ischemic heart disease (IHD) are major contributors to cardiovascular mortality in U.S. adults. This retrospective study aims to examine mortality trends and demographic disparities between 1999 and 2020. However, both diseases have been studied individually, but their combined temporal trends remain unexplored. The CDC WONDER database was used to obtain data for adults aged ≥ 45 years. AAMRs per 100,000 population and APC were calculated using Joinpoint regression, stratified by demographic, geographic, and urbanization categories. PVD and IHD together reported a total of 184,780 deaths. The overall AAMR increased from 6.9 to 8.9 per 100,000 between 1999 and 2020. Mortality rates were higher in men (8.8) compared to females (6.0) throughout the study period. Black or African American individuals had the highest AAMR (8.9), demonstrating a current surge in 2018. Similarly, non-metropolitan areas consistently experienced greater AAMR (8.5) than metropolitan areas (6.9), with a steep rise after 2018 (APC = 14.72%). Furthermore, mortality was greatest in the South; however, the Midwest region reported the highest AAMRs (8). Additionally, individuals aged 85 + had the highest CMR (44.6). Lastly, Vermont had the highest AMMRs (13.6) among other states. PVD- and IHD-related mortality depicted a recent steep increase despite an initial decline, with considerable differences across demographic and regional groups. This highlights the importance of a direct call to action by expanding preventive care, spreading awareness, and early diagnosis with management to address these inequities and decrease the growing burden.

  • Open Access

    Epidemiology of unspecified degenerative nervous system disorders: mortality trends via CDC WONDER (1999–2025)

    by Palwasha Asghar, Muhammad Jawad, Kinza Irshad, Wajeeha Iftikhar Shah, Razeena Zahid, Muhammad Talha, Asad Khan, Raghabendra Kumar Mahato

    Unspecified degenerative nervous system disorders (ICD-10 G31.9) increasingly contribute to neurological mortality, yet national temporal patterns remain u

  • Open Access

    National mortality trends in polyneuropathies and other disorders of the peripheral nervous system in the United States, 1999–2023: a CDC WONDER database analysis

    by Palwasha Asghar, Razeena Zahid, Safiullah Soomro, Arooj Ihsan Ullah, Sujata Lodh, Javeria Imran, Iftikhar Khan, Kamil Ahmad Kamil

    Background: Peripheral neuropathies and other disorders of the peripheral nervous system carry a higher mortality risk due to respiratory failure, autonomic instability, and infections. The prevalence increases with age and due to other comorbid conditions. This study evaluates mortality trends in polyneuropathies and other disorders of the peripheral nervous system in the United States from 1999 to 2023. Methods: This study analyzed publicly available data from the CDC WONDER database (1999 to 2023) using ICD-10 codes for polyneuropathy and other disorders of the peripheral nervous system (G60-G64). Join point regression was used to compute annual percent changes and 95% CIs. Results: 70,080 deaths were reported among individuals aged ≥ 55 years. Most deaths occurred at decedents’ homes (33.0%). AAMR increased from 3.18 in 1999 to 4.96 in 2023 (AAPC: 2.31%; 95% CI: 1.89–2.74%). Males maintained consistently higher AAMR than females. The greatest average CMR was demonstrated by those aged 76–85 + years (average CMR: 8.79 per 100,000 over the study period). Most deaths were observed in NH White individuals (88.5%), while Hispanic or Latino individuals had the lowest deaths (3.90%). The West exhibited the highest AAMR (4.20), and the lowest was observed in the Northeast (2.63). Substantial disparities were observed between metropolitan and non-metropolitan areas and across various states. Conclusion: Polyneuropathy related mortality has demonstrated an upward trend among adults aged ≥ 55 years from 1999 to 2023. significant inconsistencies persist with higher mortality among older adults, males, non-Hispanic white individuals, with regional disparities favoring west. This highlights the necessity of focused public health initiatives and enhanced care accessibility for all populations and areas that are at risk.

  • Trends in pulmonary embolism mortality among older adults with lung cancer in the united States, 1999–2020

    by Fnu Hafeezullah, Areesha Nawaz, Fnu Areesha, Muhammad Wassam, Muhammad Shaheer Bin Faheem, Razeena Zahid, Summaiya Salman, Muhammad Raafay Jamil

    Highlights This nationwide study analyzed mortality trends in U.S. adults aged 65 years and above, pulmonary embolism mortality among older adults with lung cancer in the United States, 1999–2020. Age-adjusted mortality rates (AAMRs) escalated substantially during the study period, with consistently higher rates observed in men and older age groups. The racial groups showed that the highest AAMRs were exhibited by the Non-Hispanic Blacks, followed by the Non-Hispanic Whites and other races. Non-metropolitan populations and residents of the Midwest and Northeast census regions endured heightened mortality rates, emphasizing the necessity for intervention modalities in the underserved communities.